European Parliament backs plans to boost joint assessment of medicines

Last week, the European Parliament adopted the Report on the Commission Proposal for a Regulation on Health Technology Assessment (HTA). In a reaction, EFPIA Director General Nathalie Moll said: “All Member States conduct clinical assessments as part of national HTA processes. It makes sense to join forces to provide one, high quality clinical assessment for use across Europe. This will support better decision-making and ultimately benefit all patients across the EU.”

Click here to read the full EFPIA statement. You’ll find the press release of the European Parliament here.